These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 7034489

  • 21. [Effects of vasoactive substances on vascular smooth muscle of various body parts in monkeys].
    Fukushima S, Ohashi T.
    Nihon Heikatsukin Gakkai Zasshi; 1989 Dec; 25(6):297-9. PubMed ID: 2518459
    [No Abstract] [Full Text] [Related]

  • 22. [Facilitation of the venoconstrictor action of 5-hydroxytryptamine by ergotamine, methysergide and LSD-25 in humans].
    Fanciullacci M, Franchi G, Sicuteri F.
    Boll Soc Ital Biol Sper; 1975 Apr 15; 51(8):517-22. PubMed ID: 1212344
    [No Abstract] [Full Text] [Related]

  • 23. Basic mechanisms of antimigraine drugs.
    Fozard JR.
    Adv Neurol; 1982 Apr 15; 33():295-307. PubMed ID: 7034488
    [No Abstract] [Full Text] [Related]

  • 24. Studies on the mechanism of action of dihydroergotamine (DHE) on the vascular bed of cat skeletal muscle.
    Chu D, Stuermer E, Berde B.
    Br J Pharmacol; 1973 Jun 15; 48(2):331P-332P. PubMed ID: 4733740
    [No Abstract] [Full Text] [Related]

  • 25. [Mechanism of action of drugs currently used in the prevention of migraine].
    Fanchamps A.
    Minerva Med; 1976 Jun 02; 67(28):1858-60. PubMed ID: 59325
    [Abstract] [Full Text] [Related]

  • 26. Isochroman-6-carboxamides as highly selective 5-HT1D agonists: potential new treatment for migraine without cardiovascular side effects.
    Ennis MD, Ghazal NB, Hoffman RL, Smith MW, Schlachter SK, Lawson CF, Im WB, Pregenzer JF, Svensson KA, Lewis RA, Hall ED, Sutter DM, Harris LT, McCall RB.
    J Med Chem; 1998 Jun 18; 41(13):2180-3. PubMed ID: 9632349
    [No Abstract] [Full Text] [Related]

  • 27. Vasodilatory mechanism of levobunolol on vascular smooth muscle cells.
    Dong Y, Ishikawa H, Wu Y, Yoshitomi T.
    Exp Eye Res; 2007 Jun 18; 84(6):1039-46. PubMed ID: 17459374
    [Abstract] [Full Text] [Related]

  • 28. Vasoactive molecules as regulators of cell growth.
    Wolf G.
    Exp Nephrol; 1994 Jun 18; 2(2):61-2. PubMed ID: 8082017
    [No Abstract] [Full Text] [Related]

  • 29. Vascular reactivity of isolated thoracic aorta of the C57BL/6J mouse.
    Russell A, Watts S.
    J Pharmacol Exp Ther; 2000 Aug 18; 294(2):598-604. PubMed ID: 10900237
    [Abstract] [Full Text] [Related]

  • 30. [A pharmacological approach to the problem of the pathology of vascular tonus].
    Votchal BE, Zhmurkin VP.
    Klin Med (Mosk); 1968 Oct 18; 46(10):10-7. PubMed ID: 5717597
    [No Abstract] [Full Text] [Related]

  • 31. Vasoconstrictive drugs increase carbonic anhydrase I in vascular smooth muscle while vasodilating drugs reduce the activity of this isozyme by a direct mechanism of action.
    Puscas I, Coltau M, Baican M, Pasca R, Domuta G, Hecht A.
    Drugs Exp Clin Res; 2001 Oct 18; 27(2):53-60. PubMed ID: 11392054
    [Abstract] [Full Text] [Related]

  • 32. Serotonin and the vascular system. Role in health and disease, and implications for therapy.
    Houston DS, Vanhoutte PM.
    Drugs; 1986 Feb 18; 31(2):149-63. PubMed ID: 3512233
    [Abstract] [Full Text] [Related]

  • 33. [Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
    Ferrari MD, Haan J, Bax WA, van Coevorden RS, Timmerman H, Meijler WJ.
    Ned Tijdschr Geneeskd; 1993 Apr 24; 137(17):846-50. PubMed ID: 8387648
    [No Abstract] [Full Text] [Related]

  • 34. Effect of antimigraine drugs on nonopioid analgesia.
    Bartolini A, Malmberg P, Bartolini R, Giotti A.
    Adv Neurol; 1982 Apr 24; 33():89-97. PubMed ID: 6275683
    [No Abstract] [Full Text] [Related]

  • 35. Direct and sensitizing effects of serotonin agonists and antagonists on vascular smooth muscle.
    Myers JH, Mecca TE, Webb RC.
    J Cardiovasc Pharmacol; 1985 Apr 24; 7 Suppl 7():S44-8. PubMed ID: 2412057
    [Abstract] [Full Text] [Related]

  • 36. [Vascular action of angiotensin: balance between peripheral vasoconstrictive influences and vasodilating influences of central origin].
    Malméjac J, Rieu M, Roux A.
    C R Seances Soc Biol Fil; 1968 Oct 19; 162(3):613-5. PubMed ID: 4302972
    [No Abstract] [Full Text] [Related]

  • 37. Evaluation of drugs applicable to treatment of migraine in the cranial circulation of the monkey.
    Lance JW, Spira PJ, Mylecharane EJ, Lord GD, Duckworth JW.
    Res Clin Stud Headache; 1978 Oct 19; 6():13-8. PubMed ID: 103151
    [No Abstract] [Full Text] [Related]

  • 38. Vasoactive agents in the microcirculation.
    Zweifach BW.
    Fed Proc; 1968 Oct 19; 27(6):1399-402. PubMed ID: 5725232
    [No Abstract] [Full Text] [Related]

  • 39. Vascular responses to potassium ion.
    Levowitz BS, Kamil N, Goldson H, Rashkin A, LaGuerre J.
    Surg Gynecol Obstet; 1969 Nov 19; 129(5):979-88. PubMed ID: 5824275
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacology of ergot alkaloids in clinical use.
    Berde B.
    Med J Aust; 1978 Nov 04; 2(3 Suppl):3-13. PubMed ID: 370528
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.